138 related articles for article (PubMed ID: 15577450)
1. Definitive, high-dose-per-fraction, conformal, stereotactic external radiation for renal cell carcinoma.
Beitler JJ; Makara D; Silverman P; Lederman G
Am J Clin Oncol; 2004 Dec; 27(6):646-8. PubMed ID: 15577450
[TBL] [Abstract][Full Text] [Related]
2. When Surgery Is Not an Option in Renal Cell Carcinoma: The Evolving Role of Stereotactic Body Radiation Therapy.
Miccio J; Johung K
Oncology (Williston Park); 2019 May; 33(5):167-73, 177. PubMed ID: 31095714
[TBL] [Abstract][Full Text] [Related]
3. Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer).
Lesueur P; Lequesne J; Barraux V; Kao W; Geffrelot J; Grellard JM; Habrand JL; Emery E; Marie B; Thariat J; Stefan D
Radiat Oncol; 2018 Jul; 13(1):138. PubMed ID: 30055640
[TBL] [Abstract][Full Text] [Related]
4. [Not Available].
Mery B; Rancoule C; Rowinski E; Bosacki C; Vallard A; Guy JB; Magné N
Bull Cancer; 2018 Dec; 105 Suppl 3():S280-S285. PubMed ID: 30595157
[TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases.
Wang CJ; Christie A; Lin MH; Jung M; Weix D; Huelsmann L; Kuhn K; Meyer J; Desai N; Kim DWN; Pedrosa I; Margulis V; Cadeddu J; Sagalowsky A; Gahan J; Laine A; Xie XJ; Choy H; Brugarolas J; Timmerman R; Hannan R
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):91-100. PubMed ID: 28587057
[TBL] [Abstract][Full Text] [Related]
6. Radiotherapy for renal-cell carcinoma.
De Meerleer G; Khoo V; Escudier B; Joniau S; Bossi A; Ost P; Briganti A; Fonteyne V; Van Vulpen M; Lumen N; Spahn M; Mareel M
Lancet Oncol; 2014 Apr; 15(4):e170-7. PubMed ID: 24694640
[TBL] [Abstract][Full Text] [Related]
7. Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma.
Wersäll PJ; Blomgren H; Lax I; Kälkner KM; Linder C; Lundell G; Nilsson B; Nilsson S; Näslund I; Pisa P; Svedman C
Radiother Oncol; 2005 Oct; 77(1):88-95. PubMed ID: 15972239
[TBL] [Abstract][Full Text] [Related]
8. Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma.
Wersäll PJ; Blomgren H; Pisa P; Lax I; Kälkner KM; Svedman C
Acta Oncol; 2006; 45(4):493-7. PubMed ID: 16760190
[No Abstract] [Full Text] [Related]
9. Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: secondary analysis of Phase I/II trials.
Ghia AJ; Chang EL; Bishop AJ; Pan HY; Boehling NS; Amini B; Allen PK; Li J; Rhines LD; Tannir NM; Tatsui CE; Brown PD; Yang JN
J Neurosurg Spine; 2016 May; 24(5):829-36. PubMed ID: 26799117
[TBL] [Abstract][Full Text] [Related]
10. Hypofractionated high-dose intensity-modulated radiotherapy (60 Gy at 2.5 Gy per fraction) for recurrent renal cell carcinoma: a case report.
Cho J; Kim GE; Rha KH; Ahn JB; Lee CG; Suh CO; Seong J; Keum KC; Kim SIe; Lee YH
J Korean Med Sci; 2008 Aug; 23(4):740-3. PubMed ID: 18756070
[TBL] [Abstract][Full Text] [Related]
11. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
Ning S; Trisler K; Wessels BW; Knox SJ
Cancer; 1997 Dec; 80(12 Suppl):2519-28. PubMed ID: 9406705
[TBL] [Abstract][Full Text] [Related]
12. Radiosurgery for solitary brain metastases using the cobalt-60 gamma unit: methods and results in 24 patients.
Coffey RJ; Flickinger JC; Bissonette DJ; Lunsford LD
Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1287-95. PubMed ID: 1646195
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic Body Radiotherapy for Kidney Cancer: Ready for Prime Time?
Carrasco-Esteban E; Barrionuevo-Castillo P; Domínguez-Rullán J; Gómez-Aparicio MA; Ferri-Molina M; Sáez-Bueno P; Zalabarría-Zarrabeitia Z; Scorsetti M; Arcangeli S; López-Campos F; Couñago F
Clin Oncol (R Coll Radiol); 2023 Mar; 35(3):163-176. PubMed ID: 36443137
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic radiation therapy in the strategy of treatment of metastatic renal cell carcinoma: A study of the Getug group.
Meyer E; Pasquier D; Bernadou G; Calais G; Maroun P; Bossi A; Theodore C; Albiges L; Stefan D; de Crevoisier R; Hennequin C; Lagrange JL; Grellard JM; Clarisse B; Licaj I; Habrand JL; Carrie C; Joly F
Eur J Cancer; 2018 Jul; 98():38-47. PubMed ID: 29864737
[TBL] [Abstract][Full Text] [Related]
15. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.
Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated postoperative irradiation in localized renal cell cancer: A case report and pertinent literature review.
Zhao XR; Shan GL; Zhang Y; Yu YH
J Cancer Res Ther; 2018; 14(Supplement):S260-S262. PubMed ID: 29578185
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic ablative body radiation therapy for primary kidney cancer: a 3-dimensional conformal technique associated with low rates of early toxicity.
Pham D; Thompson A; Kron T; Foroudi F; Kolsky MS; Devereux T; Lim A; Siva S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1061-8. PubMed ID: 25442039
[TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated stereotactic radiotherapy of paraspinal tumors: a preliminary report.
Bilsky MH; Yamada Y; Yenice KM; Lovelock M; Hunt M; Gutin PH; Leibel SA
Neurosurgery; 2004 Apr; 54(4):823-30; discussion 830-1. PubMed ID: 15046647
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame.
Nagata Y; Negoro Y; Aoki T; Mizowaki T; Takayama K; Kokubo M; Araki N; Mitsumori M; Sasai K; Shibamoto Y; Koga S; Yano S; Hiraoka M
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1041-6. PubMed ID: 11958900
[TBL] [Abstract][Full Text] [Related]
20. Intratumoural renal cell carcinoma haemorrhage following stereotactic radiotherapy: a case report.
Hilleary LA; Wratten C; Siva S; Hilleary J; Martin JM
BMC Cancer; 2019 Jul; 19(1):671. PubMed ID: 31286870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
